Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Integrating Nanotechnology with Bio-MEMS to Change the Medical and Healthcare Industry | Technavio

Technavio Research
Posted on: 25 Feb 18

Technavio’s latest market research report on the global Bio-MEMS devices market provides an analysis of the most important trends expected to impact the market outlook from 2018-2022. Technavio defines an emerging trend as a factor that has the potential to significantly impact the market and contribute to its growth or decline.

This press release features multimedia. View the full release here:

Technavio has published a new market research report on the global Bio-MEMS devices market from 2018-2022. (Graphic: Business Wire)

According to Technavio analysts, the global Bio-MEMS devices market will grow at a CAGR of over 20% during the forecast period. The growing geriatric population is a major factor driving the market’s growth.

The rising volume of the geriatric population will lead to an increase in medical services across the globe. After crossing a certain age, several health issues materialize. For instance, health conditions among the geriatric population result in immobility, mental instability, incontinence, and impaired intellect or memory. Such issues are related to the functional abilities, independence, and quality of life, which are of great concern to geriatricians and their patients. Over the last decade, the major focus was on geriatric medicine as it provides comfort and better medical services to geriatric patients.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

Save more with Technavio. Buy2 reports and get the third for FREE: View all Technavio’s current offers

In this report, Technavio highlights the integration of nanotechnology with Bio-MEMS as one of the key emerging trends driving the global Bio-MEMS devices market:

Integrating nanotechnology with Bio-MEMS

Nanotechnology is defined as the science of building devices at an atomic or nano-level. In the medical and agriculture industry, nanotechnology can be used for molecular and cell biology, nanobiotechnology, and nano bioprocessing. The major reason behind integrating nanotechnology with Bio-MEMS is that it allows a better understanding of biological mechanisms at a cellular level. Owing to its small size, Bio-NEMS have several features such as low power consumption and lower production costs. Bio-NEMS size is usually less than 100nm in diameter, but have a large surface area which makes them useful for devices such as accelerometers, drug delivery systems, energy harvesters, and gyroscopes. Even though the bio-NEMS are in the research phase and have only been manufactured in low volumes, it is expected to change the medical and healthcare industry once they have been designed and manufactured in large volumes.

“Nanotechnology with Bio-MEMS will help researchers to understand the nature of cellular interactions at a molecular level. This will provide a breakthrough in several medical techniques such as DNA or microprotein arrays, enzyme-linked immuno-sorbent assay, and fluorescence resonance energy transfer-based analysis. These techniques will benefit greatly from the integration of nanotechnology with Bio-MEMS,” says a senior analyst at Technavio for research on embedded systems.

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Global Bio-MEMS devices market segmentation

This market research report segments the global Bio-MEMS devices market into the following products (implantable and injectables) and key regions (the Americas, APAC, and EMEA).

The implantable segment held the largest market share in 2017, accounting for nearly 80% of the market. The market share for this product is expected to increase nearly 6% by 2022. The injectables segment is also expected to register a growth of nearly 5% by 2022.

The Americas was the leading region for the global Bio-MEMS devices market in 2017, accounting for a market share of 53%. By 2022, the market share of the Americas is expected to decrease nearly 2%, and EMEA will witness a growth of more than 1%.

Big savings with Technavio this February!

Get 20% OFF on all

Education Technology reports. This offer is valid only till the 28th of this month.


Celebrate winter sports with 23% OFF on all reports in the Outdoor Gear library (Offer valid from Feb 9-25).

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at

View source version on

Business Wire

Last updated on: 25/02/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.